Ultima-Tirzepatide 5 mg Ultima Pharmaceuticals

£144.00

Tirzepatide 5mg peptide for laboratory research from Ultima Pharmaceuticals. Advanced metabolic modulator targeting GLP-1 and GIP receptors for preclinical studies.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Ultima-Tirzepatide 5 mg Ultima Pharmaceuticals
Ultima-Tirzepatide 5 mg Ultima Pharmaceuticals
£144.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research Applications and Mechanisms

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist extensively studied in metabolic research applications. This 39-amino acid peptide demonstrates unique dual receptor activity, making it a valuable research tool for investigating glucose homeostasis, energy expenditure, and metabolic pathway modulation in laboratory models. Researchers at Stroid UK Shop can examine how this compound influences incretin signalling cascades and metabolic regulatory mechanisms in controlled experimental settings.

Preclinical Research Framework

Laboratory studies with tirzepatide focus on its unprecedented dual agonism profile, which differentiates it from single-receptor targeting compounds. Research teams investigate its effects on glycaemic control mechanisms, body weight regulation pathways, and lipid metabolism modulation in animal models. The compound’s ability to activate both GIP and GLP-1 receptors simultaneously provides researchers with a unique tool for studying incretin biology and metabolic syndrome pathways. Scientists examining metabolic modulators often utilise this peptide alongside other research compounds to understand complex metabolic interactions.

Laboratory Specifications

Ultima-Tirzepatide Research Specifications
Parameter Specification
Molecular Weight 4813.53 g/mol
Peptide Length 39 amino acids
Purity ≥98% (HPLC verified)
Form Lyophilised powder
Storage Conditions -20°C (powder), 2-8°C (reconstituted)
Reconstitution Bacteriostatic water recommended
Stability 24 months (powder), 30 days (solution)
CAS Number 2023788-19-2

Research institutions studying metabolic pathways often combine tirzepatide investigations with selective androgen receptor modulators and bioactive peptides to examine comprehensive metabolic responses and tissue-specific adaptations in experimental protocols.

Research Compliance and Storage

Ultima-Tirzepatide 5mg is manufactured exclusively for in-vitro research applications and laboratory studies. This compound requires proper storage at -20°C in lyophilised form and should be reconstituted using appropriate sterile solutions under controlled laboratory conditions. Research teams must maintain proper documentation and adhere to institutional guidelines when conducting studies with this peptide. All investigations must comply with applicable research regulations and ethical standards. This product is not intended for human consumption, therapeutic applications, or any use outside controlled laboratory research environments.

Related